Saturday 17 October 2026
Export CYH’s income statement to Excel — free account
Community Health Systems, Inc.
CYH Healthcare Medical Care Facilities
Community Health Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $12.5 billion, down 1.18% from fiscal 2024. In the quarter to June 2026, revenue fell 9.83%, EPS fell 75.8%, free cash flow grew 500.0% and total debt fell 11.8%, each against the same quarter a year earlier.
2.88
0.11
−3.68%
Follow CYH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
1.79 | 0.85 | 0.82 | 1.31 |
+8 more quarters Free account |
P/S ratio |
0.04 | 0.03 | 0.03 | 0.03 | |
P/FCF ratio |
0.00 | 0.00 | 1.93 | 2.84 | |
P/Operating CF |
5.14 | (1.33) | 1.57 | 6.22 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.82 | 0.80 | 0.85 | 0.86 | |
EV/EBITDA |
5.49 | 5.12 | 5.51 | 6.19 | |
EV/Operating CF |
78.43 | 78.09 | 19.43 | 22.13 | |
EV/FCF |
(54.29) | (51.25) | 48.86 | 72.26 | |
Quick Ratio |
1.14 | 1.11 | 1.06 | 1.05 | |
Current Ratio |
1.53 | 1.47 | 1.46 | 1.47 | |
Net Debt/EBITDA |
18.97 | 23.91 | 18.16 | 30.03 | |
Debt/Assets |
78.66% | 77.06% | 78.73% | 80.10% | |
Debt/Equity |
(8.23) | (8.29) | (8.97) | (8.32) | |
Asset Turnover |
0.93 | 0.91 | 0.92 | 0.93 | |
Operating CF/Net income |
1.26 | 5.12 | 2.42 | 0.53 | |
Capex/Depreciation |
(0.70) | (0.67) | (0.86) | (0.58) | |
Interest Coverage |
1.89 | 1.32 | 2.03 | 1.13 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
43.79% | 44.59% | 43.69% | 43.93% | |
Intangible Assets out of Total Assets |
0.27 | 0.24 | 0.25 | 0.27 | |
Share Based Compensation of Revenue |
0.07% | 0.10% | 0.13% | 0.00% | |
Graham Net Nets |
(22.67) | (26.90) | (26.71) | (26.35) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
55.99% | 118.03% | 121.79% | 76.32% | |
Free Cash Flow Yield |
(40.22%) | (48.58%) | 51.83% | 35.16% | |
Revenue per Share |
20.85 | 22.06 | 23.25 | 23.07 | |
Operating CF per Share |
0.65 | (2.21) | 1.99 | 0.52 | |
Capex per Share |
(0.56) | (0.57) | (0.70) | (0.46) | |
Free Cash Flow per Share |
0.09 | (2.77) | 1.29 | 0.05 | |
Cash per Share |
1.10 | 5.30 | 1.95 | 0.92 | |
Shareholders Equity per Share |
(8.59) | (9.11) | (8.68) | (9.52) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(8.59) | (9.11) | (8.68) | (9.52) | |
Free Cash Flow |
12.00 | (373.00) | 172.00 | 7.00 | |
Working Capital |
1,065.00 | 1,206.00 | 1,026.00 | 1,020.00 | |
Capital Expenditures |
(76.00) | (76.00) | (94.00) | (62.00) | |
Net Current Asset Value |
(10,260.00) | (10,632.00) | (11,129.00) | (11,315.00) | |
EV/EBIT |
7.26 | 6.63 | 7.09 | 8.29 | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.02 | |
Price to Operating Income |
0.33 | 0.27 | 0.28 | 0.33 | |
| Other line items | |||||
Average Receivables |
2,202.00 | 2,232.50 | 2,181.50 | 2,101.00 | |
Average Payables |
841.50 | 882.00 | 877.50 | 868.00 | |
Average Inventory |
298.50 | 301.50 | 326.50 | 318.00 | |
Average Assets |
12,909.00 | 13,535.00 | 13,629.00 | 13,572.00 | |
Average Common Equity |
(1,288.00) | (1,459.00) | (1,417.50) | (1,433.00) |
Columns are period end dates